Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Aventis Pharma Limited, One Onslow StreetGuildford, Surrey, GU1 4YS, UK or trading as: Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Epilim Chronosphere MR 50 mg modified release granules.
| Pharmaceutical Form |
|---|
|
Modified release granules. Sachets containing small, off-white to slightly yellow, waxy microgranules. |
Each sachet of 152 mg modified-release granules contains:
Sodium valproate 33.33 mg.
Valproic acid 14.51 mg.
Equivalent to 50 mg sodium valproate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Valproic acid |
Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. |
| List of Excipients |
|---|
|
Paraffin hard, glycerol dibehenate, silica colloidal hydrated. |
Epilim Chronosphere MR 50 mg modified release granules are filled into sachets of a paper/aluminium/ionomer resin complex.
Epilim Chronosphere sachets are available in cartons of 30 and 50 sachets.
Aventis Pharma Limited, One Onslow StreetGuildford, Surrey, GU1 4YS, UK
or trading as: Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
PL 04425/0310
Date of first authorisation: 11 July 2006
| Drug | Countries | |
|---|---|---|
| EPILIM CHRONO | Hong Kong, Ireland, Malta, Singapore, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
